Allianz Asset Management
ENZY

Allianz Asset Management’s Enzymotec Ltd ENZY Stock Holding History

Allianz Asset Management’s Portfolio ENZY Stock Details ENZY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-15,598
Closed -$112K – 2574
2015
Q1 		$112K Buy
15,598
+865
+6% +$6.12K ﹤0.01% 2218
2014
Q4 		$113K Hold
14,733
– – ﹤0.01% 2257
2014
Q3 		$98K Hold
14,733
– – ﹤0.01% 2251
2014
Q2 		$200K Buy
+14,733
New +$247K ﹤0.01% 1799

Other funds holding ENZY

PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
SPPAM
Summit Partners Public Asset Management Boston, Massachusetts $3.72B AUM 162.29% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Allianz Asset Management's ENZY Position: Q2 2015 in Review

Allianz Asset Management sold out of Enzymotec Ltd (ENZY) in Q2 2015, closing a stake of 15,598 shares — an estimated $112K sold.

Allianz Asset Management first reported a position in ENZY in Q2 2014 and held it in 4 quarters. The position peaked at $200K in Q2 2014. 18 funds tracked by Wall St. Rank hold ENZY as of Q2 2015.

  • Allianz Asset Management reported no remaining Enzymotec Ltd position as of Q2 2015 after selling out during the quarter.
  • Allianz Asset Management sold 15,598 Enzymotec Ltd shares in Q2 2015, an estimated $112K.
  • Allianz Asset Management first reported a position in Enzymotec Ltd in Q2 2014 and held it in 4 quarters.
  • Allianz Asset Management's Enzymotec Ltd position peaked at $200K in Q2 2014.
  • 18 funds tracked by Wall St. Rank held Enzymotec Ltd as of Q2 2015.

Based on Allianz Asset Management's 13F filing for Q2 2015, filed 14 Aug 2015.